DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksSchließen
Referenz
Choi D, Kim YS, Kim MJ , et al.
A phase 2, multidose, double-blind, randomized, multicenter, comparative study of zabofloxacin vs moxifloxacin in the treatment of mild to moderate community-acquired pneumonia [abstract].
Presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 9–12, 2012, San Francisco, California, L1–L294
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.